Published in Ann N Y Acad Sci on January 01, 1990
Q fever. Clin Microbiol Rev (1999) 11.32
Diagnosis of Q fever. J Clin Microbiol (1998) 4.16
Detection of Coxiella burnetti by DNA amplification using polymerase chain reaction. J Clin Microbiol (1992) 1.74
Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis. Int J Microbiol (2011) 1.33
PCR detection of Coxiella burnetii from different clinical specimens, especially bovine milk, on the basis of DNA preparation with a silica matrix. Appl Environ Microbiol (1998) 1.06
Isolation of Coxiella burnetii from heart valves of patients treated for Q fever endocarditis. J Clin Microbiol (1995) 1.04
Retrospective survey of chronic Q fever in Japan by using PCR to detect Coxiella burnetii DNA in paraffin-embedded clinical samples. J Clin Microbiol (1996) 0.96
Phylogenetic diversity of the Rickettsiae. J Bacteriol (1989) 8.48
Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine. J Bacteriol (1988) 5.43
Q fever and Coxiella burnetii: a model for host-parasite interactions. Microbiol Rev (1983) 3.76
Use of pulsed field gel electrophoresis to differentiate Coxiella burnetii strains. Ann N Y Acad Sci (1990) 3.59
Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun (1993) 3.36
Correlation of plasmid type and disease caused by Coxiella burnetii. Infect Immun (1985) 3.06
Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun (1990) 3.02
Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetii. Infect Immun (1983) 2.28
Probe directed at a segment of Rickettsia rickettsii rRNA amplified with polymerase chain reaction. J Clin Microbiol (1989) 1.91
Active transport of proline by Coxiella burnetii. J Gen Microbiol (1984) 1.86
In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob Agents Chemother (1987) 1.82
Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis (1991) 1.73
The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect Immun (1994) 1.70
Electron microscopy of the cell wall of Rickettsia prowazeki. J Bacteriol (1974) 1.69
Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines. Infect Immun (1981) 1.69
Developmental biology of Coxiella burnettii. Trends Microbiol (1999) 1.65
Differentiation of Coxiella burnetii isolates by analysis of restriction-endonuclease-digested DNA separated by SDS-PAGE. J Gen Microbiol (1991) 1.63
Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun (1994) 1.61
Isolation and characterization of a plasmid from phase I Coxiella burnetii. Infect Immun (1983) 1.61
Detection of long-term cellular immunity to Coxiella burneti as assayed by lymphocyte transformation. Infect Immun (1975) 1.55
Physiology of rickettsiae. VII. Amino acid incorporation by Coxiella burnetii and by infected hosts. J Bacteriol (1967) 1.51
A proposed model to explain persistent infection of host cells with Coxiella burnetii. J Gen Microbiol (1986) 1.51
Presence of ribosomal ribonucleic acid in the rickettsia Coxiella burneti. Biochem J (1971) 1.48
Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes. Antimicrob Agents Chemother (1989) 1.41
An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect Immun (1992) 1.39
Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Proc Natl Acad Sci U S A (2000) 1.38
Cell cycle distribution patterns and generation times of L929 fibroblast cells persistently infected with Coxiella burnetii. Infect Immun (1985) 1.38
Some physiological and biochemical effects of a Coxiella burneti lipopolysaccharide preparation on guinea pigs. Infect Immun (1974) 1.37
Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine. Infect Immun (1996) 1.37
Coxiella burnetii isolates cause genogroup-specific virulence in mouse and guinea pig models of acute Q fever. Infect Immun (2009) 1.35
Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase. J Virol (1979) 1.33
Coxiella burnetii exhibits morphological change and delays phagolysosomal fusion after internalization by J774A.1 cells. Infect Immun (2000) 1.32
Nucleotide sequence of Coxiella burnetii superoxide dismutase. Nucleic Acids Res (1990) 1.29
Cloning and sequencing of Coxiella burnetii outer membrane protein gene com1. Infect Immun (1993) 1.27
Comparison of Coxiella burnetii plasmids to homologous chromosomal sequences present in a plasmidless endocarditis-causing isolate. Ann N Y Acad Sci (1990) 1.21
Equilibrium measurements of the interactions of guanine nucleotides with Escherichia coli elongation factor G and the ribosome. Biochemistry (1976) 1.16
Deoxypyrimidine nucleoside metabolism in varicella-zoster virus-infected cells. J Virol (1978) 1.16
Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. J Infect Dis (1999) 1.15
Developmentally regulated synthesis of an unusually small, basic peptide by Coxiella burnetii. Mol Microbiol (1996) 1.14
Superoxide anion production and superoxide dismutase and catalase activities in Coxiella burnetii. J Bacteriol (1983) 1.14
Antibody-dependent cellular cytotoxicity of Coxiella burnetii-infected J774 macrophage target cells. Infect Immun (1984) 1.11
The cellular immune response to antigens of Coxiella burneti. Can J Microbiol (1974) 1.11
Partial chemical characterization of a toxic lipopolysaccharide from Coxiella burneti. Infect Immun (1974) 1.09
Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity. J Bacteriol (1991) 1.07
Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells. Antimicrob Agents Chemother (1989) 1.07
Catabolic activities of Neisseria meningitidis: utilization of glutamate. J Bacteriol (1970) 1.07
Unexpected antibiotic susceptibility of a chronic isolate of Coxiella burnetii. Ann N Y Acad Sci (1990) 1.07
Characterization of the 23S and 5S rRNA genes of Coxiella burnetii and identification of an intervening sequence within the 23S rRNA gene. J Bacteriol (1995) 1.07
Characterization of a stress-induced alternate sigma factor, RpoS, of Coxiella burnetii and its expression during the development cycle. Infect Immun (2001) 1.07
Coxiella burnetii superoxide dismutase gene: cloning, sequencing, and expression in Escherichia coli. Infect Immun (1992) 1.06
An experimental model for subclinical edema disease (Escherichia coli enterotoxemia) manifest as vascular necrosis in pigs. Am J Vet Res (1992) 1.06
Characterization and expression of the cbbE' gene of Coxiella burnetii. J Gen Microbiol (1990) 1.06
Genome size of the rickettsia Coxiella burnetii. J Bacteriol (1980) 1.05
Differential expression of translational elements by life cycle variants of Coxiella burnetii. Infect Immun (1999) 1.04
Strategy for detection and differentiation of Coxiella burnetii strains using the polymerase chain reaction. Ann N Y Acad Sci (1990) 1.03
Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever. Infect Immun (2006) 1.03
Molecular cloning of a Coxiella burnetii gene encoding a macrophage infectivity potentiator (Mip) analogue. Microbiology (1995) 1.01
Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I. Ann N Y Acad Sci (2003) 1.00
Shiga toxin-producing Escherichia coli infection: temporal and quantitative relationships among colonization, toxin production, and systemic disease. J Infect Dis (2000) 0.99
Changes in liver and L-cell plasma membranes during infection with Coxiella burnetii. Infect Immun (1978) 0.98
Detection of mip-like sequences and Mip-related proteins within the family Rickettsiaceae. Curr Microbiol (1995) 0.98
Analysis of QpRS-specific sequences from Coxiella burnetii. Ann N Y Acad Sci (1990) 0.98
Analysis of Coxiella burnetii isolates in cell culture and the expression of parasite-specific antigens on the host membrane surface. Acta Virol (1991) 0.97
Cloning and functional expression of the Coxiella burnetii citrate synthase gene in Escherichia coli. Infect Immun (1987) 0.96
Pathophysiologic features of Q fever-infected guinea pigs. Am J Vet Res (1975) 0.95
Transformation of Rochalimaea quintana, a member of the family Rickettsiaceae. J Bacteriol (1990) 0.93
Transformation and genomic restriction mapping of Rochalimaea spp. Acta Virol (1991) 0.93
Stability of plasmid sequences in an acute Q-fever strain of Coxiella burnetii. J Gen Microbiol (1988) 0.92
Coxiella burnetii infection increases transferrin receptors on J774A. 1 cells. Infect Immun (1999) 0.91
Intervention with Shiga toxin (Stx) antibody after infection by Stx-producing Escherichia coli. J Infect Dis (2000) 0.91
Rate of synthesis of beta L-lipovitellin in the liver of immature chicks treated with 17beta estradiol. Biochem Biophys Res Commun (1975) 0.90
Comparison of ribosomes from Coxiella burnetii and Escherichia coli by gel electrophoresis, protein synthesis, and immunological techniques. J Bacteriol (1978) 0.88
A systematic approach to evaluate humoral and cellular immune responses to Coxiella burnetii immunoreactive antigens. Clin Microbiol Infect (2009) 0.88
Identification and cloning of a 27-kDa Coxiella burnetii immunoreactive protein. Ann N Y Acad Sci (1990) 0.87
Age-related resistance to 987P fimbria-mediated colonization correlates with specific glycolipid receptors in intestinal mucus in swine. Infect Immun (1994) 0.87
Ribosomes and ribonucleic acids of Coxiella burneti. J Bacteriol (1973) 0.87
U.V. induced covalent crosslinking of E. coli ribosomal RNA to specific proteins. Biochem Biophys Res Commun (1976) 0.86
A plasmid-encoded surface protein found in chronic-disease isolates of Coxiella burnetti. Infect Immun (1991) 0.86
DNA probes for detecting Coxiella burnetii strains. Acta Virol (1992) 0.86
Coxiella burnetii acid phosphatase inhibits the release of reactive oxygen intermediates in polymorphonuclear leukocytes. Infect Immun (2010) 0.85
Protein-tyrosine phosphatase activity of Coxiella burnetii that inhibits human neutrophils. Acta Virol (1997) 0.85
Analysis of strain-specific plasmid sequences from Coxiella burnetii. Acta Virol (1991) 0.84
Analysis of the cbhE' plasmid gene from acute disease-causing isolates of Coxiella burnetii. Gene (1991) 0.84
Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates. Antimicrob Agents Chemother (1991) 0.84
Physical mapping of the Coxiella burnetii genome. Acta Virol (1991) 0.84
Antineoplastic agents. Part 409: Isolation and structure of montanastatin from a terrestrial actinomycete. Bioorg Med Chem (1999) 0.83
Mapping the minimal contiguous gene segment that encodes functionally active Shiga-like toxin II. Infect Immun (1991) 0.82
Genomic analysis of phase I and II Coxiella burnetii with restriction endonucleases. J Gen Microbiol (1985) 0.82
The partition region of plasmid QpH1 is a member of a family of two trans-acting factors as implied by sequence analysis. Gene (1995) 0.82
Host response to infection by Coxiella burneti. Can J Microbiol (1975) 0.82
Mitogenic and protective activity associated with a lipopolysaccharide from Coxiella burnetii. Can J Microbiol (1978) 0.81
Edema disease as a model for systemic disease induced by Shiga toxin-producing E. coli. Adv Exp Med Biol (1999) 0.81